Ats Corporation · TSX:ATS
Ats — Q3 2024 Earnings Presentation
14 slides from Ats's earnings presentation, Feb 7, 2024
Slide 1: Q3 2024 Earnings Call
Q3 2024 Earnings Call February 7, 2024 8:30am ET
Slide 2: Today's Hosts and Forward Looking Statements
Today's Hosts Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer Forward Looking Statements Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements
Slide 3: Non-IFRS and Other Financial Measures
Non-IFRS and Other Financial Measures Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, “organic revenue”, “adjusted net income”, “adjusted earnings fr
Slide 4: Q3 2024 Highlights
Q3 2024 Highlights Strong organic revenue growth and trailing twelve month book-to-bill ratio1 at or above 1.0 in all markets except transportation ▪ Q3 Order Bookings¹ down ~32% y/y to $668MM (prior year included $221M USD EV Order Bookings or approximately $300.2M CAD) ▪ Q3 Revenues up ~16% y/y to
Slide 5: Outlook
Outlook Order Backlog1 provides a solid foundation to execute on our growth strategy • Life Sciences $875MM: funnel remains strong, with focus on strategic areas • Transportation $564MM: includes approx. $200MM on delayed projects; funnel and long-term fundamentals strong while near-term market for
Slide 6: Financial Results
Financial Results Y/Y Y/Y Y/Y Y/Y (C$ mm, except per share Q3 Q3 Change Change F2024 F2023 Change Change data) F2024 F2023 ($) (%) ($) (%) Revenues $752.0 $647.0 $105.0 16.2% $2,241.4 $1,846.6 $394.8 21.4% Revenue Growth: QTD YTD Earnings from operations 78.5 56.0 22.5 40.2% 240.6 170.6 70.0 41.0% O
Slide 7: Summary
Summary ▪ Strong revenue growth, adjusted earnings from operations1 in line with our expectations, and diversified Order Bookings1 and Order Backlog1 ▪ Estimated Q4-F24 Order Backlog-to-revenue conversion 36% to 39% ▪ No change to long-term outlook in strategic end-markets ▪ Avidity acquisition comp
Slide 8: ATS
ATS
Slide 9: WATS
WATS
Slide 10: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 10
Slide 11: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly The following table reconciles organic revenue to the most directly comparable IFRS comparable IFRS measure (net income) (in millions of dollars): measure (re
Slide 12: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted earnings from operations to the most The following table reconciles adjusted basic earnings per share to the most directly comparable IFRS measures (net income) (in millions of dollars): directly c
Slide 13: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to adjusted EBITDA to the most directly The following table reconciles free cash flow to the most directly comparable comparable IFRS measure (in millions of dollars): IFRS measure (in millions of
Slide 14: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ mm) Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 F2022 F2023 F2023 F2023 F2023 F2024 F2024 F
ATS Corporation Common Shares — Q3 2024 Earnings Presentation on 6ix